12nd Department of Medicine, University of Debrecen, Debrecen, Hungary; 2Glycominds Ltd., Lod, Israel; 3Laboratory of Clinical Immunology, University of Debrecen, Debrecen, Hungary; 4Institute of Surgery, University of Debrecen, Debrecen, Hungary; 51st Department of Medicine, Csolnoky F. County Hospital, Veszprem, Hungary; 61st Department of Medicine, Peterfi Hospital, Budapest, Hungary; 71st Department of Medicine, University of Szeged, Szeged, Hungary; 82nd Department of Medicine, Semmelweis University, Budapest, Hungary; 9INOVA Diagnostics, Inc., San Diego, California; 101st Department of Medicine, Semmelweis University, Budapest, Hungary; and 11Department of Medicine, National Medical Center, Budapest, Hungary
Reprint requests and correspondence: Peter L. Lakatos, M.D., Ph.D., 1st Department of Medicine, Semmelweis University, Koranyi St. 2/A, H-1083 Hungary.
CONFLICT OF INTEREST
Guarantor of the article: Peter L. Lakatos, M.D., Ph.D.
Specific author contributions: Maria Papp: designed the study, performed serology analysis, was involved in patient recruitment, supervised the collection of patients and controls and manuscript preparation; Ildiko Foldi, Judit Tumpek, Sandor Sipka, and Miklos Udvardy: performed serology analysis and were involved in manuscript preparation; Istvan Altojay, Tamas Dinya, Laszlo Lakatos, Agota Kovacs, Tamas Molnar, Zsolt Tulassay, Pal Miheller, Tamas Szamosi, and Janos Papp: were involved in patient recruitment and manuscript preparation; Nir Dotan and Gary L. Norman: were involved in manuscript preparation and in overseeing data analysis; Peter L. Lakatos: designed the study, was involved in patient recruitment, data analysis, and supervised the collection of patients and controls and manuscript preparation. All authors have approved the final draft submitted.
Financial support: We thank the Mecenatura Trust 11/2005, the Richter Gedeon Gastroenterology Research, and the ETT Health Research Council (ETT041/2006) for their financial support of this work. None of the funding bodies were involved in the study design, collection, analysis, and interpretation of the data, or in the preparation of the manuscript.
Potential competing interests: Nir Dotan is an employee of Glycominds Ltd. and Gary L. Norman is an employee of Inova Diagnostics Inc.
Received June 13, 2007; accepted October 2, 2007.
